| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 24 May 2025 | 12 May 2025 |
| Healthcare Global Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/05/2025 inter alia to consider and approve Audited Financial Results (both Standalone and Consolidated) of the Company for the quarter and year ended March 31 2025 (Audited Financial Results). The Board of Directors of the Company at its meeting held on May 24, 2025 has considered and approved the Audited Financial Results (Standalone and Consolidated) for quarter and year ended March 31, 2025. (As Per BSE Announcement Dated on :24.05.2025) | ||
| Board Meeting | 21 Feb 2025 | 24 Feb 2025 |
| Disclosure under Regulation 30 | ||
| Board Meeting | 14 Feb 2025 | 5 Feb 2025 |
| Quarterly Results Healthcare Global Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2025 ,inter alia, to consider and approve and take on record the Unaudited Financial Results (both Standalone and Consolidated) of the Company for the quarter and nine months ended December 31, 2024 The Board Meeting to be held on 13/02/2025 has been revised to 14/02/2025 The Board Meeting of the Company would commence on Thursday, February 13, 2025 and would continue on Friday, February 14, 2025, and that the Unaudited Financial Results of the Company shall be discussed and considered by the Board on February 14, 2025. (As per BSE Announcement Dated on 11/02/2025) Considered and approved the unaudited financial results of the Company for the quarter and nine months ended Deceber 31, 2024. (As Per BSE Announcement Dated on 14.02.2025) | ||
| Board Meeting | 7 Feb 2025 | 7 Feb 2025 |
| Changes in directorship of HealthCare Global Enterprises Limited (the Company) | ||
| Board Meeting | 9 Nov 2024 | 24 Oct 2024 |
| Healthcare Global Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2024 inter alia to consider and approve and take on record the unaudited financial results for the quarter and six months ended Sept 30 2024. Results-Financial Results for September 30, 2024 (As Per BSE Announcement Dated on: 09/11/2024) | ||
| Board Meeting | 8 Aug 2024 | 25 Jul 2024 |
| Healthcare Global Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2024 inter alia to consider and approve and take on record the Unaudited Financial Results (both Standalone and Consolidated) of the Company for the quarter ended June 30 2024 (Unaudited Financial Results). Unuaudited Financial Results of the Company for the quarter ended June 30, 2024 (As Per BSE Announcement dated on 08.08.2024) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.